TABLE 6.
The dose adjustment rate of inhaled drugs containing glucocorticoid of clinical phenotypes.
| Dose adjustment rate (n,%) | Neutrophilic | Eosinophilic | Mixed granulocytic | ||||
|---|---|---|---|---|---|---|---|
| Doxophylline group | Non‐doxophylline group | Doxophylline group | Non‐doxophylline group | Doxophylline group | Non‐doxophylline group | ||
| 1st month | Reduced | 0 (0.0%) | 0 (0.0%) | 1 (4.8%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| Increased | 2 (3.3%) | 3 (5.0%) | 0 (0.0%) | 0 (0.0%) | 2 (4.5%) | 3 (6.8%) | |
| P Value | 0.990 | 0.476 | 0.990 | ||||
| 3rd months | Reduced | 10 (16.7%) | 7 (11.7%) | 1 (4.8%) | 8 (38.1%) | 5 (11.4%) | 7 (15.9%) |
| Increased | 2 (3.3%) | 17 (28.3%) | 4 (40.0%) | 1 (9.1%) | 7 (15.9%) | 4 (9.1%) | |
| P Value | 0.003 | 0.016 | 0.170 | ||||
| 6th months | Reduced | 13 (21.7%) | 6 (10.0%) | 7 (33.3%) | 1 (4.8%) | 5 (11.4%) | 10 (22.7%) |
| Increased | 3 (5.0%) | 9 (15.0%) | 0 (0.0%) | 4 (19.0%) | 3 (6.8%) | 6 (13.6%) | |
| P value | 0.016 | 0.007 | 0.572 | ||||